anisodamine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YK; Fu, Y; Jia, CK; Qin, QF; Weng, J; Yang, QZ; Yu, WM | 1 |
| Guo, SH; Zhang, DF; Zhou, YX | 1 |
2 other study(ies) available for anisodamine and Liver Dysfunction
| Article | Year |
|---|---|
Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Choledocholithiasis; Common Bile Duct; Cost Savings; Cost-Benefit Analysis; Dexamethasone; Drainage; Feasibility Studies; Female; Glucocorticoids; Hepatectomy; Hospital Costs; Humans; Length of Stay; Lithiasis; Liver Diseases; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Solanaceous Alkaloids; Time Factors; Treatment Outcome; Young Adult | 2015 |
[Prostacyclin and other drugs protective against experimental liver damage in rats].
Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Drug Synergism; Epoprostenol; Female; Galactosamine; Liver Diseases; Male; Neostigmine; Prostaglandins F; Rats; Rats, Inbred Strains; Solanaceous Alkaloids | 1986 |